Psychedelics could be a game-changer in treating mental health issues. All of which could help create big opportunities for ...

Psychedelic drugs have entered the mainstream ... illnesses such as depression and schizophrenia. Image source: Getty Images. Several of these drugmakers are publicly traded and are receiving ...

An investment in SEEL could offer some much-needed sector diversity for psychedelic stock investors, as Seelos is involved with testing protocols for a wide array of diseases, including Huntington ...

Most stocks in the psychedelic space took a hit on ... Bank Of America Analyst Expects Stock To Hit $1,500 Per Share Photo: Shutterstock News ...

Psychedelic-medicine stocks dropped sharply ... Trump Media expects nearly $70 million from move that helped cause stock’s skid Barron's: Nvidia Soars, History Advises Caution.

These ‘next-generation psychedelics’ aim to overcome some of the limitations of using classical psychedelics as therapeutic ...

As psilocybin mushrooms become the most popular psychedelic in the United States, some states have started to ease ...

I think they felt seen and heard in a way that many patients don’t, going into surgery. I’m thinking about parallels with the ...